Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

Overview

Journal J Natl Compr Canc Netw

Specialty Oncology

Date 2017 Apr 14

PMID 28404761

Citations 638

Authors

David S Ettinger

Douglas E Wood

Dara L Aisner

Wallace Akerley

Jessica Bauman

Lucian R Chirieac

Thomas A DAmico

Malcolm M DeCamp

Thomas J Dilling

Michael Dobelbower

Robert C Doebele

Ramaswamy Govindan

Matthew A Gubens

Mark Hennon

Leora Horn

Ritsuko Komaki

Rudy P Lackner

Michael Lanuti

Ticiana A Leal

Leah J Leisch

Rogerio Lilenbaum

Jules Lin

Billy W Loo Jr

Renato Martins

Gregory A Otterson

Karen Reckamp

Gregory J Riely

Steven E Schild

Theresa A Shapiro

James Stevenson

Scott J Swanson

Kurt Tauer

Stephen C Yang

Kristina Gregory

Miranda Hughes

Affiliations

Soon will be listed here.

Abstract

This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.

Citing Articles

Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism.

Yan L, Liu Y, Huang Y, Sun X, Jiang H, Gu J Cancer Biol Med. 2025; 22(2).

PMID: 39995202 PMC: 11899589. DOI: 10.20892/j.issn.2095-3941.2024.0385.

Efficacy of contrast versus non-contrast CT surveillance among patients surviving two years without recurrence after surgery for stage I lung cancer.

Jeon Y, Kang D, Lee J, Park S, Cho J, Choi Y Sci Rep. 2025; 15(1):6142.

PMID: 39979491 PMC: 11842762. DOI: 10.1038/s41598-025-90124-x.

Recent advances in the methods and clinical applications of next-generation sequencing in genomic profiling and precision cancer therapy.

Alsaiari A EXCLI J. 2025; 24:15-33.

PMID: 39967910 PMC: 11830917. DOI: 10.17179/excli2024-7594.

Difficulties in the diagnosis and treatment of axillary malignant triton tumors: A case report.

Zhou Y, Li L, Lan F, Qin L, Huang D Oncol Lett. 2025; 29(3):147.

PMID: 39877059 PMC: 11774139. DOI: 10.3892/ol.2025.14893.

miR-224-5p Suppresses Non-Small Cell Lung Cancer via IL6ST-Mediated Regulation of the JAK2/STAT3 Pathway.

Tian J, He Y, Zhang Z, Zhu Y, Ren H, Zhang L Thorac Cancer. 2025; 16(2):e15516.

PMID: 39840666 PMC: 11751714. DOI: 10.1111/1759-7714.15516.